Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Revision: v3.4.2 to the record history. The previous government funding notice (Revision: v3.4.1) was removed.
    Difference
    0.9%
    Check dated 2026-02-11T10:19:59.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A general site-wide notice about government funding and NIH Clinical Center status was added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-04T06:41:21.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    UI changes add a Show glossary option and green/red color-coded highlights for additions and deletions, with an updated Revision label (v3.4.0). The No FEAR Act data entry was removed.
    Difference
    1%
    Check dated 2026-01-28T06:19:49.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The study history shows a new revision (v3.3.4) added and the previous revision (v3.3.3) removed; these are internal record-keeping updates to the record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:14:12.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Version 2026-01-02 added core sections to the study record—Outcome Measures, Study Description, Oversight, and Study Status—representing substantive updates to the trial's documentation. The 2025-09-25 deletion indicates that prior content was removed.
    Difference
    0.8%
    Check dated 2026-01-06T23:14:36.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The history now includes a new revision entry (v3.3.3) and removes the older entries for HHS Vulnerability Disclosure and revision v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-23T09:54:15.000Z thumbnail image

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.